BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8687451)

  • 21. A carboxylic acid isostere screen of the DHODH inhibitor Brequinar.
    DeRatt LG; Christine Pietsch E; Tanner A; Shaffer P; Jacoby E; Wang W; Kazmi F; Zhang X; Attar RM; Edwards JP; Kuduk SD
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127589. PubMed ID: 33007394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effects.
    Schwartsmann G; Peters GJ; Laurensse E; de Waal FC; Loonen AH; Leyva A; Pinedo HM
    Biochem Pharmacol; 1988 Sep; 37(17):3257-66. PubMed ID: 2840910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redoxal as a new lead structure for dihydroorotate dehydrogenase inhibitors: a kinetic study of the inhibition mechanism.
    Knecht W; Löffler M
    FEBS Lett; 2000 Feb; 467(1):27-30. PubMed ID: 10664450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in Vivo inhibition of immunoglobulin secretion by the immunosuppressive compound HR325 is reversed by exogenous uridine.
    Thomson TA; Spinella-Jaegle S; Francesconi E; Meakin C; Millet S; Flao KL; Hidden H; Ruuth E
    Scand J Immunol; 2002 Jul; 56(1):35-42. PubMed ID: 12100469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.
    He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
    Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and functional comparison of agents interfering with dihydroorotate, succinate and NADH oxidation of rat liver mitochondria.
    Jöckel J; Wendt B; Löffler M
    Biochem Pharmacol; 1998 Oct; 56(8):1053-60. PubMed ID: 9776318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structures of human dihydroorotate dehydrogenase with and without inhibitor reveal conformational flexibility in the inhibitor and substrate binding sites.
    Walse B; Dufe VT; Svensson B; Fritzson I; Dahlberg L; Khairoullina A; Wellmar U; Al-Karadaghi S
    Biochemistry; 2008 Aug; 47(34):8929-36. PubMed ID: 18672895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.
    Chen SF; Ruben RL; Dexter DL
    Cancer Res; 1986 Oct; 46(10):5014-9. PubMed ID: 3019518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis.
    Björnberg O; Rowland P; Larsen S; Jensen KF
    Biochemistry; 1997 Dec; 36(51):16197-205. PubMed ID: 9405053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-arthritic effects of KF20444, a new immunosuppressive compound inhibiting dihydroorotate dehydrogenase, on rat collagen-induced arthritis.
    Kobayashi K; Nakashima A; Nagata H; Nakajima H; Yamaguchi K; Sato S; Miki I
    Inflamm Res; 2001 Jan; 50(1):24-31. PubMed ID: 11235018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological effects of the dihydroorotate dehydrogenase inhibitor polyporic acid, a toxic constituent of the mushroom Hapalopilus rutilans, in rats and humans.
    Kraft J; Bauer S; Keilhoff G; Miersch J; Wend D; Riemann D; Hirschelmann R; Holzhausen HJ; Langner J
    Arch Toxicol; 1998 Nov; 72(11):711-21. PubMed ID: 9879809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies.
    Schwartsmann G; Dodion P; Vermorken JB; ten Bokkel Huinink WW; Joggi J; Winograd B; Gall H; Simonetti G; van der Vijgh WJ; van Hennik MB
    Cancer Chemother Pharmacol; 1990; 25(5):345-51. PubMed ID: 2306795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent Brequinar Sodium.
    Pitts WJ; Jetter JW; Pinto DJ; Orwat MJ; Batt DG; Sherk SR; Petraitis JJ; Jacobson IC; Copeland RA; Dowling RL; Jaffee BD; Gardner TL; Jones EA; Magolda RL
    Bioorg Med Chem Lett; 1998 Feb; 8(3):307-12. PubMed ID: 9871675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase.
    Boa AN; Canavan SP; Hirst PR; Ramsey C; Stead AM; McConkey GA
    Bioorg Med Chem; 2005 Mar; 13(6):1945-67. PubMed ID: 15727850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indirect inhibition of mitochondrial dihydroorotate dehydrogenase activity by nitric oxide.
    Beuneu C; Auger R; Löffler M; Guissani A; Lemaire G; Lepoivre M
    Free Radic Biol Med; 2000 Apr; 28(8):1206-13. PubMed ID: 10889450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rat dihydroorotate dehydrogenase: isolation of the recombinant enzyme from mitochondria of insect cells.
    Knecht W; Altekruse D; Rotgeri A; Gonski S; Löffler M
    Protein Expr Purif; 1997 Jun; 10(1):89-99. PubMed ID: 9179295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated plasma dihydroorotate in Miller syndrome: Biochemical, diagnostic and clinical implications, and treatment with uridine.
    Duley JA; Henman MG; Carpenter KH; Bamshad MJ; Marshall GA; Ooi CY; Wilcken B; Pinner JR
    Mol Genet Metab; 2016 Sep; 119(1-2):83-90. PubMed ID: 27370710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into the mechanism of oxidation of dihydroorotate to orotate catalysed by human class 2 dihydroorotate dehydrogenase: a QM/MM free energy study.
    Alves CN; Silva JR; Roitberg AE
    Phys Chem Chem Phys; 2015 Jul; 17(27):17790-6. PubMed ID: 26087682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histidine to alanine mutants of human dihydroorotate dehydrogenase. Identification of a brequinar-resistant mutant enzyme.
    Davis JP; Copeland RA
    Biochem Pharmacol; 1997 Aug; 54(4):459-65. PubMed ID: 9313772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools.
    Pizzorno G; Wiegand RA; Lentz SK; Handschumacher RE
    Cancer Res; 1992 Apr; 52(7):1660-5. PubMed ID: 1551097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.